Can a Single IM Ketorolac Dose Be Given Two Weeks After Oral Ketorolac?
Yes, a single intramuscular dose of ketorolac can be safely administered two weeks after completing a five-day oral ketorolac course.
Rationale Based on FDA Labeling
The FDA-approved labeling for ketorolac explicitly states that "the combined duration of use of intravenous or intramuscular dosing of ketorolac tromethamine and oral ketorolac tromethamine is not to exceed 5 days" 1, 2. This restriction applies to continuous or overlapping treatment periods, not to separate treatment courses separated by a washout interval.
Key Points from Drug Labeling:
- The 5-day maximum duration refers to combined IV/IM and oral use within a single treatment episode 1, 2
- The concern is cumulative exposure during acute treatment, not lifetime cumulative exposure
- No FDA restriction exists on re-initiating ketorolac after an appropriate drug-free interval
Pharmacokinetic Support
The elimination half-life of ketorolac is approximately 4.5-7 hours in adults (longer in elderly patients at 6.1-7.0 hours) 3. After five half-lives (approximately 35 hours, or less than 2 days), ketorolac is essentially completely eliminated from the body. Two weeks provides more than adequate clearance time—approximately 240 hours, or roughly 40-50 elimination half-lives.
Clinical Context
The FDA's 5-day restriction exists primarily to minimize:
- Gastrointestinal toxicity from prolonged NSAID exposure
- Renal dysfunction risk
- Bleeding complications
- Cardiovascular events
These risks are associated with continuous exposure, not with intermittent courses separated by drug-free intervals that allow tissue recovery and restoration of normal prostaglandin-mediated protective mechanisms.
Important Caveats
Before administering the IM dose, verify:
- No ongoing NSAID use during the intervening two weeks (including over-the-counter ibuprofen, naproxen, aspirin)
- No new contraindications have developed (renal function changes, bleeding events, cardiovascular events, planned surgery)
- No concurrent antiplatelet agents beyond what was present during the first course (particularly important given case reports of epidural hematoma with ketorolac plus fluoxetine and other antiplatelet medications) 4
- Patient age and renal function remain stable (elderly patients and those with renal impairment have prolonged elimination) 3
Dosing Recommendation
For the single IM dose after the two-week interval:
- Standard adult (age 17-64, weight >50 kg, normal renal function): 30 mg IM 1
- Elderly (≥65 years), renally impaired, or weight <50 kg: Consider 15 mg IM 1
The two-week drug-free interval effectively "resets" the treatment clock, allowing safe re-initiation for a new acute pain episode.